AMGN / Amgen Inc
as of 2026-02-10
Bias: MixedRisk: ElevatedMixed structure, RSI overbought, risk elevated
Last
375.82
1D -2.21% • 5D +9.03% • 1M +13.85%
Company
AMGEN Inc is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. With a strong commitment to scientific research, AMGEN focuses on areas such as oncology, cardiovascular disease, and inflammation. The company's portfolio includes several blockbuster drugs, and it emphasizes the importance of biotechnology in addressing unmet medical needs. AMGEN operates globally, leveraging advanced technology and a robust pipeline of drug candidates to improve patient outcomes.
Mini chart (last 120 D1 closes)
2025-09-17 → 2026-02-09
1D
-2.21%
5D
+9.03%
1M
+13.85%
Vol (20d)
38.6%
Weather meter
Overall55
Trend60
Volatility52
Sentiment50
Technicals
MA20
345.56
Above short-term trend
MA50
335.99
Above medium-term trend
MA200
—
RSI14
72.6
Overbought
What traders watch now
Support (MA50)
335.99
Resistance (MA200)
—
Key risk
Momentum exhaustion
Time horizon
2–10 trading days